Orthocell announces research collaboration

Company News

by Jessica Amir

Orthocell Limited (ASX:OCC) has entered into a research collaboration with Johnson and Johnson for its stem cell products.

The product, Ortho-ATI, is a non-surgical approach that treats resistant tendons and ligament injuries.

The companies will conduct a collaborative study in the first quarter of 2017 and conduct a trial with leading orthopaedic surgeons.

Ortho-ATI is available in Australian and New Zealand.

Orthocell posted a net loss $3.8 million at 30 June 2016.
 

Jessica Amir

Finance News Network
Jessica is a senior finance journalist and presents the Market Outlook, Market at Midday and Market Wrap. She also presents ASX company news and interviews CEOs. She joined FNN in January 2017 with six years of broadcast journalism experience. She worked as a journalist and producer with Sky News Business, ABC 1, ABC's The Business and ABC24. She also worked in regional Australia for Prime 7 and WIN News as a TV reporter. In her prior life she worked as a financial planner.